InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Williams Sarah Joanne. Director active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 1 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €1k. History available since 29 May 2026. The latest transaction was disclosed on 29 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration